Dr Sotir Polena, MD | |
172 E Main St, Huntington, NY 11743-2948 | |
(631) 385-0022 | |
(631) 385-0896 |
Full Name | Dr Sotir Polena |
---|---|
Gender | Male |
Speciality | Interventional Cardiology |
Experience | 29 Years |
Location | 172 E Main St, Huntington, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023206505 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 243927 (New York) | Secondary |
207RI0011X | Internal Medicine - Interventional Cardiology | 243927 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ns/lij Hs Huntington Hospital | Huntington, NY | Hospital |
North Shore University Hospital | Manhasset, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Shore - Lij Medical Pc | 3375701568 | 5099 |
Rajeswara Rao Patcha Md Pc | 9638068323 | 10 |
News Archive
Taro Pharmaceutical Industries Ltd. reported today that it has received final approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for cetirizine hydrochloride oral solution, 1 mg / 1 mL ("Cetirizine Oral Solution").
Health loss caused by type 2 diabetes will more than double in Australia by 2023, as health loss from most other major causes falls, according to new research by The University of Queensland's (UQ) School of Population Health.
The National Cancer Institute has awarded a five-year, $13.6 million grant to the University of North Carolina at Chapel Hill's Carolina Center of Cancer Nanotechnology Excellence (C-CCNE) based at the UNC Lineberger Comprehensive Cancer Center, for research to improve the diagnosis and treatment of cancer through applying/using advances in nanotechnology.
Eating a diet rich in both soy protein and isoflavones can protect menopausal women from bone weakening and osteoporosis, according to the results of a preliminary study presented today at the Society for Endocrinology annual conference in Edinburgh.
› Verified 9 days ago
Entity Name | Rajeswara Rao Patcha Md Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609851807 PECOS PAC ID: 9638068323 Enrollment ID: O20040311000846 |
News Archive
Taro Pharmaceutical Industries Ltd. reported today that it has received final approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for cetirizine hydrochloride oral solution, 1 mg / 1 mL ("Cetirizine Oral Solution").
Health loss caused by type 2 diabetes will more than double in Australia by 2023, as health loss from most other major causes falls, according to new research by The University of Queensland's (UQ) School of Population Health.
The National Cancer Institute has awarded a five-year, $13.6 million grant to the University of North Carolina at Chapel Hill's Carolina Center of Cancer Nanotechnology Excellence (C-CCNE) based at the UNC Lineberger Comprehensive Cancer Center, for research to improve the diagnosis and treatment of cancer through applying/using advances in nanotechnology.
Eating a diet rich in both soy protein and isoflavones can protect menopausal women from bone weakening and osteoporosis, according to the results of a preliminary study presented today at the Society for Endocrinology annual conference in Edinburgh.
› Verified 9 days ago
Entity Name | North Shore - Lij Medical Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
Taro Pharmaceutical Industries Ltd. reported today that it has received final approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for cetirizine hydrochloride oral solution, 1 mg / 1 mL ("Cetirizine Oral Solution").
Health loss caused by type 2 diabetes will more than double in Australia by 2023, as health loss from most other major causes falls, according to new research by The University of Queensland's (UQ) School of Population Health.
The National Cancer Institute has awarded a five-year, $13.6 million grant to the University of North Carolina at Chapel Hill's Carolina Center of Cancer Nanotechnology Excellence (C-CCNE) based at the UNC Lineberger Comprehensive Cancer Center, for research to improve the diagnosis and treatment of cancer through applying/using advances in nanotechnology.
Eating a diet rich in both soy protein and isoflavones can protect menopausal women from bone weakening and osteoporosis, according to the results of a preliminary study presented today at the Society for Endocrinology annual conference in Edinburgh.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Sotir Polena, MD 172 E Main St, Huntington, NY 11743-2948 Ph: (631) 385-0022 | Dr Sotir Polena, MD 172 E Main St, Huntington, NY 11743-2948 Ph: (631) 385-0022 |
News Archive
Taro Pharmaceutical Industries Ltd. reported today that it has received final approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for cetirizine hydrochloride oral solution, 1 mg / 1 mL ("Cetirizine Oral Solution").
Health loss caused by type 2 diabetes will more than double in Australia by 2023, as health loss from most other major causes falls, according to new research by The University of Queensland's (UQ) School of Population Health.
The National Cancer Institute has awarded a five-year, $13.6 million grant to the University of North Carolina at Chapel Hill's Carolina Center of Cancer Nanotechnology Excellence (C-CCNE) based at the UNC Lineberger Comprehensive Cancer Center, for research to improve the diagnosis and treatment of cancer through applying/using advances in nanotechnology.
Eating a diet rich in both soy protein and isoflavones can protect menopausal women from bone weakening and osteoporosis, according to the results of a preliminary study presented today at the Society for Endocrinology annual conference in Edinburgh.
› Verified 9 days ago
Richard B Schwarz, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 325 Park Ave, Huntington, NY 11743 Phone: 631-351-3784 Fax: 631-547-5349 | |
Dr. James I Klepper, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 E Main St, Suite 200, Huntington, NY 11743 Phone: 631-549-5700 Fax: 631-549-1991 | |
Dr. Adam Ross Davis, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 172 E Main St, Huntington, NY 11743 Phone: 631-385-0022 Fax: 631-385-0896 | |
Dr. Jalil Anwar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 161 E Main St, Huntington, NY 11743 Phone: 631-760-8207 Fax: 631-549-1084 | |
Frederick Joseph Gandolfo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 E Main St Ste 1-4, Huntington, NY 11743 Phone: 631-350-6077 | |
Ritsa Marie Frousios, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 270 Park Ave, Huntington, NY 11743 Phone: 631-351-2000 |